551 related articles for article (PubMed ID: 31748285)
1. Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.
Ali D; Callan N; Ennis S; Powell R; McGuire S; McGregor G; Weickert MO; Miller MA; Cappuccio FP; Banerjee P
BMJ Open; 2019 Nov; 9(11):e027984. PubMed ID: 31748285
[TBL] [Abstract][Full Text] [Related]
2. Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction.
Ali D; Tran P; Ennis S; Powell R; McGuire S; McGregor G; Kimani PK; Weickert MO; Miller MA; Cappuccio FP; Banerjee P
ESC Heart Fail; 2023 Aug; 10(4):2487-2498. PubMed ID: 37280726
[TBL] [Abstract][Full Text] [Related]
3. Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Chirinos JA; Bhattacharya P; Kumar A; Proto E; Konda P; Segers P; Akers SR; Townsend RR; Zamani P
J Am Heart Assoc; 2019 Feb; 8(4):e011457. PubMed ID: 30764699
[TBL] [Abstract][Full Text] [Related]
4. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
[TBL] [Abstract][Full Text] [Related]
5. Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction.
Maréchaux S; Samson R; van Belle E; Breyne J; de Monte J; Dédrie C; Chebai N; Menet A; Banfi C; Bouabdallaoui N; Le Jemtel TH; Ennezat PV
J Card Fail; 2016 Jan; 22(1):3-11. PubMed ID: 26386451
[TBL] [Abstract][Full Text] [Related]
6. Association between sleep-disordered breathing and arterial stiffness in heart failure patients with reduced or preserved ejection fraction.
Suzuki S; Yoshihisa A; Sato Y; Watanabe S; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
ESC Heart Fail; 2018 Jun; 5(3):284-291. PubMed ID: 29460495
[TBL] [Abstract][Full Text] [Related]
7. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA
J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960
[TBL] [Abstract][Full Text] [Related]
8. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
[TBL] [Abstract][Full Text] [Related]
9. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
10. Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction.
Kresoja KP; Rommel KP; Fengler K; von Roeder M; Besler C; Lücke C; Gutberlet M; Desch S; Thiele H; Böhm M; Lurz P
Circ Heart Fail; 2021 Mar; 14(3):e007421. PubMed ID: 33706547
[TBL] [Abstract][Full Text] [Related]
11. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
12. Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction.
Hummel SL; Seymour EM; Brook RD; Sheth SS; Ghosh E; Zhu S; Weder AB; Kovács SJ; Kolias TJ
Circ Heart Fail; 2013 Nov; 6(6):1165-71. PubMed ID: 23985432
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.
Beale AL; Nanayakkara S; Segan L; Mariani JA; Maeder MT; van Empel V; Vizi D; Evans S; Lam CSP; Kaye DM
JACC Heart Fail; 2019 Mar; 7(3):239-249. PubMed ID: 30819380
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
[TBL] [Abstract][Full Text] [Related]
15. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
[TBL] [Abstract][Full Text] [Related]
16. Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction.
Shimizu T; Yoshihisa A; Kanno Y; Takiguchi M; Sato A; Miura S; Nakamura Y; Yamauchi H; Owada T; Abe S; Sato T; Suzuki S; Oikawa M; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(7):H1123-9. PubMed ID: 26297226
[TBL] [Abstract][Full Text] [Related]
17. Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction.
Tartière-Kesri L; Tartière JM; Logeart D; Beauvais F; Cohen Solal A
J Am Coll Cardiol; 2012 Jan; 59(5):455-61. PubMed ID: 22281248
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.
Mohammed SF; Borlaug BA; Roger VL; Mirzoyev SA; Rodeheffer RJ; Chirinos JA; Redfield MM
Circ Heart Fail; 2012 Nov; 5(6):710-9. PubMed ID: 23076838
[TBL] [Abstract][Full Text] [Related]
19. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fraction.
Fujimoto N; Prasad A; Hastings JL; Bhella PS; Shibata S; Palmer D; Levine BD
Am Heart J; 2012 Dec; 164(6):869-77. PubMed ID: 23194487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
